Opening Asia for Russia

Sinovac vaccine has been shown to be effective for adults under 60

08.05.2021 131 просмотров

The COVID-19 vaccine, developed by the Chinese biopharmaceutical company Sinovac Biotech, is effective in preventing coronavirus infection in adults under 60 years old, experts from the World Health Organization (WHO) say.

The WHO Strategic Advisory Group of Experts (SAGE) on Immunization has evaluated the Sinovac vaccine, which has previously entered Phase 3 clinical trials in China, Brazil, Chile, Indonesia and Turkey.

Sinovac 1.jpg

“We are extremely confident that two doses of Sinovac is effective in preventing of COVID-19 infection in adults aged 18 to 59,” says the SAGE report, published on the WHO website.

Sinovac 2.jpg

To date, Sinovac has been approved for use in 32 countries and regions. The facility has already provided 260 million doses of the drug worldwide, according to SAGE.

Sinovac 4.jpg

Новости партнёров